Search

Denali Therapeutics Inc

Closed

SectorHealthcare

26.95 4.42

Overview

Share price change

24h

Current

Min

25.52

Max

26.71

Key metrics

By Trading Economics

Income

102K

-128M

EPS

-0.69

Employees

507

EBITDA

-937K

-126M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+28.81% upside

Dividends

By Acuity

Next Earnings

7 Aug 2026

Market Stats

By TradingEconomics

Market Cap

1.1B

4.1B

Previous open

22.53

Previous close

26.95

News Sentiment

By Acuity

50%

50%

160 / 342 Healthcare

Denali Therapeutics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

8 Jul 2026, 23:51 UTC

News

Broadcom shares rise in after-market hours as analysts project $172 billion in revenue next year, driven by AI infrastructure spending.

8 Jul 2026, 23:51 UTC

News
Social Media

Costco Wholesale reported net sales of $29.24 billion for June but shares declined in after-hours trading amid mixed investor sentiment and broader market trends.

8 Jul 2026, 23:46 UTC

News
ETF Constituents
Macro News
Correlated Moves

The Financial Select Sector SPDR Fund is higher in after-market trading, supported by strong seasonal patterns and movements in major bank holdings.

8 Jul 2026, 23:41 UTC

News
Social Media
Correlated Moves

Advanced Micro Devices shares are declining in after-hours trading amid negative sentiment in semiconductor stocks, following the announcement of its upcoming earnings report.

8 Jul 2026, 23:41 UTC

Social Media
News

NVIDIA Corp shares declined in after-market trading amid concerns over AI spending and competition. Analysts note cautious investor sentiment contributing to the bearish outlook.

8 Jul 2026, 23:41 UTC

News
Social Media
Correlated Moves

Micron Technology shares traded higher after notable options activity, with $7.2 million in orders for $815 7/17 Puts contributing to a total premium of over $21.5 million.

8 Jul 2026, 23:36 UTC

News

PayPal Holdings Inc. shares fell in after-market trading amid geopolitical tensions and investor risk aversion following President Trump's announcement on the Iran ceasefire.

8 Jul 2026, 23:26 UTC

News

Lam Research Corporation will hold a financial conference call on July 29, 2026, to discuss June quarter results. Shares are higher in after-market trading.

8 Jul 2026, 23:11 UTC

Correlated Moves
Macro News
ETF Constituents
News

The Consumer Discretionary Select Sector SPDR Fund is higher in after-market trading, bolstered by Levi Strauss & Co.'s strong Q2 results and summer performance trends.

8 Jul 2026, 23:06 UTC

News

United Airlines shares traded lower in after-market hours following a judge's ruling to allow a class-action lawsuit over misleading "window seat" charges.

8 Jul 2026, 23:06 UTC

News

Monster Beverage Corp announced a 2-for-1 stock split, effective August 10, 2026. Shares are trading higher in after-market hours following the news.

8 Jul 2026, 23:06 UTC

Correlated Moves
News
Social Media
ETF Constituents

SPDR Dow Jones Industrial Average ETF Trust is lower in after-market hours, reflecting declines in key contributors amid rising inflation concerns from escalating Middle East tensions.

8 Jul 2026, 23:01 UTC

News

Geopolitical tensions following U.S. strikes in Iran have boosted United States Oil Fund LP in after-market trading, reflecting strong upward momentum since Wednesday's close.

8 Jul 2026, 20:13 UTC

ETF Constituents
Correlated Moves
News

The Vanguard Large-Cap ETF is lower in after-hours trading, reflecting broader market declines amid rising crude oil prices and escalating tensions in the Middle East.

8 Jul 2026, 20:07 UTC

News
Correlated Moves

Bitcoin is trading lower amid heightened geopolitical tensions and rising inflation concerns. Earlier in the session, Bitcoin briefly declined significantly before recovering slightly.

8 Jul 2026, 20:07 UTC

News
Correlated Moves

Geopolitical tensions following President Trump's U.S.-Iran ceasefire announcement support a modest rise in CAD/HKD during Wednesday's session. The pair is up since Tuesday's close.

8 Jul 2026, 20:07 UTC

News
Correlated Moves

Bitcoin is trading lower amid heightened geopolitical tensions following President Trump's declaration on Iran. The asset remains under pressure from rising inflation concerns.

8 Jul 2026, 20:06 UTC

Social Media
Macro Event
News

Cisco Systems Inc shares are higher today following the US Wholesale Inventories report, which showed a smaller-than-expected increase for May. Concerns about a price breakdown persist.

8 Jul 2026, 20:04 UTC

News

J B Hunt Transport shares rise as Stephens initiates Overweight rating and TD Cowen raises price target to $265 ahead of earnings report.

8 Jul 2026, 20:04 UTC

Correlated Moves
Social Media
News

Intuit Inc. shares are lower amid an investigation into potential securities fraud by Bleichmar Fonti & Auld LLP related to pricing issues ahead of tax season.

8 Jul 2026, 20:04 UTC

Social Media
News
Correlated Moves

Amazon shares are lower as TD Cowen lowers its price target to $340 ahead of earnings, amid concerns over significant investments and high borrowing.

8 Jul 2026, 20:04 UTC

News
Social Media
Correlated Moves

Alphabet Inc shares are lower despite confirmation of a major presence at the Calgary Stampede, reflecting broader market trends amid global tensions.

8 Jul 2026, 20:04 UTC

News
Correlated Moves

Alphabet Inc shares are lower, affected by declines in the Interactive Media & Services sub-sector and a drop in the S&P 500 Index.

8 Jul 2026, 20:04 UTC

Social Media
News
Correlated Moves

Meta Platforms Inc. shares are lower as France's competition authority mandates renewed negotiations with local media over unpaid publishing fees, amid broader market declines.

8 Jul 2026, 20:04 UTC

Social Media
News
Correlated Moves

Qualcomm Inc is rising amid strong gains in the Semiconductors sector. Social media discussions note key resistance levels around $185.13 and $186.32.

8 Jul 2026, 20:03 UTC

ETF Constituents
News
Correlated Moves

Vanguard Small-Cap ETF is lower as Goldman Sachs warns of waning favorable conditions for small-cap stocks amid rising interest burdens and declining holdings.

8 Jul 2026, 20:03 UTC

Macro News
News
ETF Constituents
Correlated Moves

The Industrial Select Sector SPDR Fund is trading lower as rising oil prices and inflation concerns pressure the sector amid geopolitical tensions.

8 Jul 2026, 20:02 UTC

News

Expedia Group Inc shares declined as geopolitical tensions rose after President Trump's Iran ceasefire remarks, raising concerns about travel demand and costs.

8 Jul 2026, 20:02 UTC

News

NXP Semiconductors NV is trading higher, supported by Cantor Fitzgerald's endorsement and positive outlook for its automotive segment growth through 2027.

8 Jul 2026, 19:57 UTC

Social Media
News

Tesla Inc. shares are lower today amid operational pressures and competitive developments, including scrutiny over Full Self-Driving and new competition in robotics.

Peer Comparison

Price change

Denali Therapeutics Inc Forecast

Price Target

By TipRanks

28.81% upside

12 Months Forecast

Average 34.38 USD  28.81%

High 42 USD

Low 23 USD

Based on 11 Wall Street analysts offering 12 month price targets forDenali Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

11 ratings

11

Buy

0

Hold

0

Sell

Sentiment

By Acuity

160 / 342 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Denali Therapeutics Inc

Denali Therapeutics Inc., a biopharmaceutical company, develops a portfolio of product candidates engineered to cross the blood-brain barrier for neurodegenerative diseases and lysosomal storage diseases in the United States. The company's transport vehicle (TV)-enabled programs include DNL310 ETV, an IDS enzyme replacement therapy program for MPS II; TAK-594/DNL593 which is in Phase 1/II for frontotemporal dementia-granulin; DNL126 program for MPS IIIA; and DNL622 for MPS I, as well as other preclinical programs that target amyloid beta and HER2. Its brain-penetrant small molecule programs comprise BIIB122/DNL151 LRRK2 inhibitor program for Parkinson's disease; SAR443820/DNL788 RIPK1 inhibitor program for CNS disease; DNL343 eIF2B Activator program for amyotrophic lateral sclerosis; and SAR443122/DNL758 RIPK1 inhibitor program for peripheral inflammatory diseases. It also provides early stage program include TAK-594/DNL593 program for FTD-GRN; DNL126 program for MPS IIIA, a Sanfilippo Syndrome A; DNL622 for MPS I which is Hurler syndrome; Antibody Transport Vehicle Amyloid beta program; Oligonucleotide Transport Vehicle platform, a novel class of biotherapeutics to address the root cause of diseases through modulation of gene expression; and other TV-enabled discovery programs. The company has collaboration agreements with Biogen MA Inc. and Biogen International GmbH; Genzyme Corporation; Takeda Pharmaceutical Company Limited; F-star Gamma Limited, F-star Biotechnologische Forschungs-und Entwicklungsges m.b.H, and F-star Biotechnology Limited; and Genentech, Inc. The company was formerly known as SPR Pharma Inc. and changed its name to Denali Therapeutics Inc. in March 2015. Denali Therapeutics Inc. was incorporated in 2013 and is headquartered in South San Francisco, California.
help-icon Live chat